Quebec doctors are being offered $100 for every new patient they put on cholesterol-lowering statin drugs as part of a major, federally subsidized study that's raising questions about the influence of the pharmaceutical industry on health research.
Critics say the OBSTAT trial seems more about drug marketing than science, getting thousands more people to take an already popular medicine.
More
No comments:
Post a Comment